The NCRI Children’s Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of childhood cancer. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for childhood cancer patients.  

The NCRI Children’s Group consists of an executive group, chaired by Dr Julia Chisholmwhich provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI Children’s Group also has several subgroups that develop research in areas of strategic need. Members are competitively recruited to the executive group and subgroups twice a year.  

Group Chair: Dr Julia Chisholm

Phil Ancliff, Consultant Haematologist, Great Ormond Street Hospital for Children NHS Foundation Trust

Simon Bailey, Professor of Paediatric Neuro-Oncology and Consultant Paediatric Oncologist, Royal Victoria Infirmary

Mark Brougham, Consultant Paediatric Oncologist, Royal Hospital for Sick Children

Gladstone Amos Burke, NIHR CRN: Cancer National Specialty Lead for Children & Young People’s Cancer, University of Cambridge

Maria Antonietta Cerone, Post-Doc, Cancer Research UK (CRUK) London – Clinical Trials Unit @ University College London (UCL)

Edmund Cheesman, Consultant Paediatric Histopathologist, Royal Manchester Children’s Hospital

Julia Chisholm, Consulant in Paediatric and TYA oncology, Royal Marsden NHS Foundation Trust

Mark Davies, Medical Oncologist, Swansea University

Martin Elliott, Consultant Paediatric Oncologist, Leeds Teaching Hospitals NHS Trust – Leeds General Infirmary

Hany Gabra, Consultant Paediatric Surgeon, Royal Victoria Infirmary

Ashley Gamble, Executive Director, Children’s Cancer and Leukaemia Group (CCLG)

Simon Gates, Statistician, University of Birmingham

Juliet Gray, Consultant in Paediatric Oncology, University Hospital Southampton NHS Foundation Trust

Richard Grundy, Professor of Paediatric Neuro-oncology and Cancer Biology, University of Nottingham

Lisa Howell, Consultant Paediatric Oncologist, Alder Hey Children’s NHS Foundation Trust

Ian Kamaly-Asl, Consultant Paediatric Neurosurgeon, University of Manchester

Pamela Kearns, Director, Birmingham Cancer Research UK Clinical Trials Unit (CRCTU), King’s College London (KCL)

John Paul Kilday, Consultant Paediatric Neuro-oncologist & Honorary Senior Lecturer in Paediatric Oncology, Royal Manchester Children’s Hospital

Loveday Langton

Henry Mandeville, Clinical Oncologist, Royal Marsden NHS Foundation Trust

Lynley Marshall, Consultant in Paediatric Drug Development, Institute of Cancer Research (ICR)

John Moppett, Consultant Paediatric Haematologist, University Hospitals Bristol NHS Foundation Trust

Bruce Morland, Professor, Birmingham Women’s and Children’s NHS Foundation Trust

Bob Phillips, Senior Clinical Academic, University of York, and Hon Consultant in Paed/TYA Oncology, Leeds, University of York

Angela Polanco

Sheona Scales, ECMC Paediatric Network Manager, Cancer Research UK (CRUK)

Sara Stoneham, University College London Hospitals NHS Foundation Trust (UCLH)

Fatima Sulaiman, Head of Research, Blood Cancer UK

Mary Taj, Institute of Cancer Research (ICR)

Deborah Tweddle, Professor of Paediatric Oncology and Honorary Consultant in Paediatric & Adolescent Oncology, Newcastle upon Tyne Hospitals NHS Foundation Trust